This text of New Mexico § 59A-22-49.4 (Prescription drugs; prohibited formulary changes;) is published on Counsel Stack Legal Research, covering New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
notice requirements. A. As of January 1, 2014, an individual or group health insurance policy, health care plan or certificate of health insurance that is delivered, issued for delivery or renewed in this state and that provides prescription drug benefits categorized or tiered for purposes of cost-sharing through deductibles or coinsurance obligations shall not make any of the following changes to coverage for a prescription drug within one hundred twenty days of any previous change to coverage for that prescription drug, unless a generic version of the prescription drug is available:
(1)reclassify a drug to a higher tier of the formulary;
(2)reclassify a drug from a preferred classification to a non-preferred classification, unless that reclassification results in the drug moving to a l
Free access — add to your briefcase to read the full text and ask questions with AI
notice requirements. A. As of January 1, 2014, an individual or group health insurance policy, health care plan or certificate of health insurance that is delivered, issued for delivery or renewed in this state and that provides prescription drug benefits categorized or tiered for purposes of cost-sharing through deductibles or coinsurance obligations shall not make any of the following changes to coverage for a prescription drug within one hundred twenty days of any previous change to coverage for that prescription drug, unless a generic version of the prescription drug is available: (1) reclassify a drug to a higher tier of the formulary; (2) reclassify a drug from a preferred classification to a non-preferred classification, unless that reclassification results in the drug moving to a lower tier of the formulary; (3) increase the cost-sharing, copayment, deductible or co-insurance charges for a drug; (4) remove a drug from the formulary; (5) establish a prior authorization requirement; (6) impose or modify a drug's quantity limit; or (7) impose a step-therapy restriction. B. The insurer shall give the affected insured at least sixty days' advance written notice of the impending change when it is determined that one of the following modifications will be made to a formulary: (1) reclassification of a drug to a higher tier of the formulary; (2) reclassification of a drug from a preferred classification to a non-preferred classification, unless that reclassification results in the drug moving to a lower tier of the formulary; (3) an increase in the cost-sharing, copayment, deductible or coinsurance charges for a drug; (4) removal of a drug from the formulary; (5) addition of a prior authorization requirement; (6) imposition or modification of a drug's quantity limit; or (7) imposition of a step-therapy restriction for a drug. C. Notwithstanding the provisions of Subsections A and B of this section, the insurer may immediately and without prior notice remove a drug from the formulary if the drug: (1) is deemed unsafe by the federal food and drug administration; or (2) has been removed from the market for any reason. D. The insurer shall provide to each affected insured the following information in plain language regarding prescription drug benefits: (1) notice that the insurer uses one or more drug formularies; (2) an explanation of what the drug formulary is; (3) a statement regarding the method the insurer uses to determine the prescription drugs to be included in or excluded from a drug formulary; and (4) a statement of how often the insurer reviews the contents of each drug formulary. E. As used in this section: (1) "formulary" means the list of prescription drugs covered by a policy, plan or certificate of health insurance; and (2) "step therapy" means a protocol that establishes the specific sequence in which prescription drugs for a specified medical condition and medically appropriate for a particular patient are to be prescribed.